The DEA New Orleans Division conducted a five-year review of the data on synthetic substances reported in the National Forensic Laboratory Information System for their area of responsibility. The findings revealed that Louisiana submitted the majority of reports for synthetic cannabinoid substance and synthetic cathinones substance for 2013 to 2017...

DEA Acting Administrator Uttam Dhillon announces Operation Crystal Shield in response to a dramatic increase in methamphetamine trafficking through eight major cities in the U.S. The press conference took place at the DEA Field Division Headquarters in Atlanta, Georgia on February 20, 2020.

The 2019 National Drug Threat Assessment (NDTA) is a comprehensive strategic assessment of the threat posed to the United States by domestic and international drug trafficking and the abuse of both licit and illicit drugs. The report combines federal, state, local, and tribal law enforcement reporting; public health data; open...

This report describes the methods and results of an assessment of the reach and impact of community outreach activities of the DEA 360 Strategy in Newark. Results are based on a summary of metrics compiled from each program facilitator, as well as from interviews with community partners from across the...

Matthew J. Strait, Senior Policy Advisor, Diversion Control Division-DEA; Before the House Energy and Commerce Committee-Subcommittee on Health, for a Hearing Entitled: Cannabis Policy-For the New Decade

A strategic planning guide for preventing drug misuse among college students.

Hearing Entitled “Tackling the Opioid Crisis: A Whole-of-Government Approach” December 17, 2019

The vast majority of drugs entering Chicago and the surrounding area, including fentanyl and fentanyl-related substances (FRS), heroin, cocaine, and methamphetamine, continue to be smuggled across the United States–Mexico border. Availability and abuse of these drugs is high, with opioids being the most prevalent in major cities and methamphetamine in...

This document is an internal Drug Enforcement Administration quality system document. The effective period of the document is October 07, 2019 to June 20, 2021 and it is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some document...

The Fentanyl Signature Profiling Program (FSPP) performs in-depth chemical analyses on fentanyl and fentanyl-related exhibits obtained from seizures made throughout the United States. This report details the results and conclusions derived from these analyses that are reported on a quarterly basis. FSPP data is not intended to reflect U.S. market...